Abstract:Introduction Two million older Americans from underrepresented racial and ethnic minority groups (URGs) have early-stage Alzheimer's disease and related dementias (ADRD). Recent neuroimaging and clinical trials focus on individuals with early-stage ADRD, which is crucial to the development of disease modification strategies. Despite recognition of the need to increase URG engagement in these studies, enrollment remains low. A major barrier to improving URG participation rates is the lack of best practices in recruitment and referral processes. The aim of these analyses was to take a first step in examining reasons for these disparities by comparing referral sources for ADRC enrollment of URG participants with early-stage ADRD. Methods These analyses included data from 48,330 participants across 46 ADRCs, obtained through the National Alzheimer's Coordinating Center Uniform Data Set. Descriptive statistics from 5 racial/ethnic groups at baseline (visit 1) were compared using one-way analysis of variance models (ANOVAs) and chi-square tests. Generalized multinomial logistic regression models were used to examine the association of racial/ethnic group and the types of referral sources (professional, non-professional and other), with ‘non-professional’ as the reference category. The ‘professional’ category included referrals made by healthcare professionals or ADRC staff, while the ‘non-professional’ category included referrals made by family and friends. This association was examined in three samples: (1) the entire sample, (2) individuals with a baseline diagnosis of mild cognitive impairment (MCI) or dementia and a baseline global Clinical Depression Rating (CDR) of 0.5 or 1, and (3) individuals who had completed magnetic resonance imaging (MRI) at any point and a baseline diagnosis of MCI or dementia and a baseline global CDR of 0.5 or 1. Significance was set at p <0.05. Results Descriptive statistics are shown in Table 1. The sample included 35,358 (73.2%) Non-Hispanic White participants, 4,138 (8.6%) Hispanic participants, 6,766 (14%) Non-Hispanic Black participants, 1,392 (2.9%) Non-Hispanic Asian participants, and 676 (1.4%) participants of other racial and ethnic groups. Across the entire sample, Non-Hispanic Black participants were less likely to be referred by a professional contact than Non-Hispanic White participants, but more likely to be referred by family or friends (Table 2). A similar pattern was observed in participants who had a diagnosis of MCI or dementia and a global CDR of 0.5 or 1 at baseline - both overall (Table 3) and in those who had completed MRI (Table 4). These findings remained significant after adjusting for age, gender, education, and CDR score. Conclusions A lack of healthcare professional-facilitated recruitment may contribute to the disproportionately lower research participation in URGs in early-stage ADRD, including those who are willing to complete investigations such as MRI. There is a need at a national level to develop recruitment strategies to increase URG representation, particularly for Non-Hispanic Black older adults. Further studies are needed to examine how factors affecting health equity may contribute to this disparity.

Alzheimer's Disease and Related Dementias Diagnosis in the United States Among US-Born and Foreign-Born White, Black, Hispanic, and Asian Older Adults

Racial and Ethnic Differences in the Population-Attributable Fractions of Alzheimer Disease and Related Dementias

Modifiable Risk Factors for Alzheimer's Disease and Related Dementias Among Middle Eastern and North African Immigrants to the United States

Healthcare expenditures among older immigrants in the US with Alzheimer's disease and related dementias: Population-based study between 2007 and 2020

Alzheimer's disease and related dementia diagnoses among American Indian and Alaska Native adults aged ≥45 years, Indian Health Service System, 2016-2020

Regional variation in diagnostic intensity of dementia among older U.S. adults: An observational study

Racial and Ethnic Disparities in Participation at Alzheimer's Disease Research Centers

Geographic disparities in Alzheimer's disease and related dementia mortality in the US: Comparing impacts of place of birth and place of residence

Referral Sources Across Racial and Ethnic Groups at Alzheimer's Disease Research Centers

Racial Differences in the Effect of Alzheimer’s Disease on Adherence to Medication Therapy for Chronic Diseases

A systematic review/meta‐analysis of prevalence and incidence rates illustrates systemic underrepresentation of individuals racialized as Asian and/or Asian‐American in ADRD research

INTERACTION BETWEEN NATIVITY AND NEIGHBORHOOD ON DEMENTIA RISK: FINDINGS FROM TEN YEARS OF NATIONAL US DATA

Disparities in neighbourhood characteristics and 10-year dementia risk by nativity status

Forecasting the 20-Year Incidence of Dementia by Socioeconomic Status, Race/Ethnicity, and Region Based on Mid-Life Risk Factors in a U.S. Nationally Representative Sample

Analysis of Alzheimer's Disease-Related Mortality Rates Among the Elderly Populations Across the United States: An Analysis of Demographic and Regional Disparities from 1999 to 2020

Understanding Racial Disparities in Dementia Prevalence Among Veterans

FC9: Ethno-racial identity and cognitive impairment: A population-based study

Disparities in Alzheimer Disease and Mild Cognitive Impairment Among Native Hawaiians and Pacific Islanders

Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial

The disproportionate burden of Alzheimer's disease and related dementias (ADRD) in diverse older adults diagnosed with cancer

Racial and ethnic differences in disease course Medicare expenditures for beneficiaries with dementia